DURHAM, N.C. (AP) ¿ Arigene Co., a Korean medical equipment maker, said Tuesday it is terminating its tender offer for outstanding shares of biopharmaceutical company Trimeris Inc.

Arigene couldn't secure enough financing for the offer, the company said.

Trimeris agreed to be acquired on Oct. 2 for about $81 million, or $3.60 per share, and the tender offer was extended until Monday on Nov. 17. Arigene had asked for another extension but Trimeris didn't grant it.

When the offer expired Monday, about 19.3 million, or 86.4 percent of outstanding Trimeris shares, had been tendered. Arigene said the tendered shares will be returned to their holders.

The news sent Trimeris shares down 54 cents, or 17 percent, to $2.64. The stock has traded between 84 cents and $3.68 over the past year.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Stocks

The Stock Market Has Every Reason to See a Fresh Rally

The Stock Market Has Every Reason to See a Fresh Rally

3 Simple Tips on Investing From TheStreet's Jim Cramer

3 Simple Tips on Investing From TheStreet's Jim Cramer

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Tesla's Supercharger Network Is Booming -- Here's Why That's a Concern

Tesla's Supercharger Network Is Booming -- Here's Why That's a Concern

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly